Blueprint Medicines Corp (BPMC) — Capital Reinvestment Ratio
Blueprint Medicines Corp (BPMC) has a Capital Reinvestment Ratio of 0.00x as of September 2020, meaning it reinvests 0% of its operating cash flow ($622.33 Million) in capital expenditures ($6.00K). Check Blueprint Medicines Corp tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Blueprint Medicines Corp Capital Reinvestment Ratio (2020–2020)
This chart tracks Blueprint Medicines Corp's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Blueprint Medicines Corp generate cash.
Annual Capital Reinvestment Ratio for Blueprint Medicines Corp (2020–2020)
Year-by-year Capital Reinvestment Ratio for Blueprint Medicines Corp from 2020 to 2020. See Blueprint Medicines Corp free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.01x | $387.04 Million | $3.16 Million | — |